Y-mAbs Therapeutics, Inc.
YMAB
$5.05
-$0.22-4.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 60.31M | 67.23M | 68.12M | 77.81M | 75.75M |
| Total Receivables | 17.74M | 19.69M | 19.92M | 22.19M | 20.59M |
| Inventory | 8.00M | 7.21M | 9.56M | 8.50M | 8.45M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.40M | 4.37M | 1.46M | 18.27M | 3.48M |
| Total Current Assets | 90.45M | 98.51M | 99.06M | 126.76M | 108.27M |
|
|
|||||
| Total Current Assets | 90.45M | 98.51M | 99.06M | 126.76M | 108.27M |
| Net Property, Plant & Equipment | 762.00K | 859.00K | 1.13M | 1.36M | 1.33M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.21M | 2.28M | 2.37M | 2.45M | 2.54M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.19M | 18.26M | 18.37M | 13.46M | 11.17M |
| Total Assets | 112.61M | 119.90M | 120.92M | 144.04M | 123.32M |
|
|
|||||
| Total Accounts Payable | 4.63M | 6.66M | 7.88M | 10.19M | 6.73M |
| Total Accrued Expenses | 7.53M | 8.18M | 10.25M | 6.59M | 5.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 455.00K | 630.00K | 776.00K | 842.00K | 888.00K |
| Total Finance Division Other Current Liabilities | 6.35M | 8.22M | 6.39M | 25.85M | 4.37M |
| Total Other Current Liabilities | 6.35M | 8.22M | 6.39M | 25.85M | 4.37M |
| Total Current Liabilities | 18.96M | 23.70M | 25.29M | 43.47M | 17.61M |
|
|
|||||
| Total Current Liabilities | 18.96M | 23.70M | 25.29M | 43.47M | 17.61M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 148.00K | 190.00K | 299.00K | 432.00K | 293.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.05M | 4.01M | 2.90M | 4.80M | 6.23M |
| Total Liabilities | 23.16M | 27.90M | 28.49M | 48.70M | 24.13M |
|
|
|||||
| Common Stock & APIC | 580.39M | 576.88M | 572.81M | 567.64M | 562.44M |
| Retained Earnings | -492.33M | -487.14M | -480.35M | -473.35M | -464.10M |
| Treasury Stock & Other | 1.40M | 2.26M | -36.00K | 1.05M | 848.00K |
| Total Common Equity | 89.46M | 92.00M | 92.43M | 95.34M | 99.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 89.46M | 92.00M | 92.43M | 95.34M | 99.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 89.46M | 92.00M | 92.43M | 95.34M | 99.19M |
|
|
|||||